Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-1 Anti-Trypsin in Cardiac Surgery
NCT02191839Phase 2Unknown
- Sponsor
- Soroka University Medical Center
- Start
- Jul 2014
- Primary completion
- Jul 2015
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of alpha-1-proteinase inhibitor in Systemic Inflammatory Response Syndrome (SIRS), sponsored by Soroka University Medical Center. Status: unknown.
02
Drugs
alpha-1-proteinase inhibitor
03
Conditions
Systemic Inflammatory Response Syndrome (SIRS)
Beyond the preview
Go deeper on NCT02191839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191839.